| Nabi Biopharmaceuticals
2005 ReBrand 100: merit
Order of information below: Before Image, Rebrand Images, Summary/Rebrand Strategy, Credits
Summary: Challenge - In 2003, Nabi Biopharmaceuticals shifted its focus from a plasma product company into an innovative biopharmaceuticals company. Revenue grew significantly and advances were made in the clinic. The company became a successful biopharmaceutical leader thus changing their established market perception. Strategy - To reflect this new company vision, a new visual identity was developed, including a corporate logo, a content-managed website, a style guide maintaining this identity and other print collateral. Result - This new image was aligned with the company's accomplishments, attracting a renewed interest from key constituents, including investors and the press. Credits : Client : Nabi Biopharmaceuticals - www.nabi.com Creative Firm : Weymouth Design - www.weymouthdesign.com Writers : Feinstein Kean Healthcare - www.fkhealth.com 2004 Annual Report : Art Director: Mike Weymouth, Robert Krivicich, Weymouth Design, Inc. Designer: Lucas Roy, Weymouth Design, Inc. Copywriter: Jani Bergan, Feinstein Kean Healthcare Photography: Mike Weymouth and Greg Hren Identity : Art Director: Mike Weymouth, Robert Krivicich, Weymouth Design, Inc. Designer: Lucas Roy, Weymouth Design, Inc. Folder : Art Director: Weymouth, Robert Krivicich, Weymouth Design, Inc. Designer: Lucas Roy, Weymouth Design, Inc. Corporate Style Guide : Art Director: Robert Krivicich, Weymouth Design, Inc. Designer: Lucas Roy, Weymouth Design, Inc. Photography: Mike Weymouth and Greg Hren Website : Art Director: Mike Weymouth, Tom Kraft, Weymouth Design, Inc. Designer: Chris Geiser and Sean Barclay, Weymouth Design, Inc. Writer: Fran DeVellis, Feinstein Kean Healthcare Photography: Mike Weymouth and Greg Hren Programming: Mark Annese and Matt Christian, Weymouth Design, Inc. [back] |
